Publication Name	World Journal of Diabetes
Manuscript ID	46796
Country	Greece

Received	2019-02-24 10:38
Peer-Review Started	2019-02-26 00:26
To Make the First Decision	2019-03-11 03:39
Return for Revision	2019-03-11 09:08
Revised	2019-03-13 10:33
Second Decision	2019-03-20 08:37
Accepted by Journal Editor-in-Chief	2019-03-20 13:24
Accepted by Executive Editor-in-Chief	2019-03-28 03:08
Articles in Press	2019-03-28 03:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-04-15 02:02
Publish the Manuscript Online	2019-04-15 08:21

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun
Manuscript Source	Invited Manuscript
All Author List	Spyridon N Karras, Theocharis Koufakis, Pantelis Zebekakis and Kalliopi Kotsa
ORCID	Author(s) ORCID Number Spyridon N Karras http://orcid.org/0000-0002-4225-2746 Theocharis Koufakis http://orcid.org/0000-0002-5853-1352 Pantelis Zebekakis http://orcid.org/0000-0001-8821-406X Kalliopi Kotsa http://orcid.org/0000-0003-2376-740X
Funding Agency and Grant Number
Corresponding Author	Spyridon N Karras, MD, PhD, Academic Fellow, Lecturer, Senior Researcher, Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki 55535, Greece. karraspiros@yahoo.gr
Key Words	Type 1 diabetes; Insulin; Adjunctive therapies; Cardiovascular risk
Core Tip	Adjunctive to insulin therapies in type 1 diabetes (T1D) may have a role in optimizing metabolic control, assisting weight management and reducing glycemic variability. Specific safety issues should be further assessed by future studies, before these therapeutic choices become widely available for T1D management.
Publish Date	2019-04-15 08:21
Citation	Karras SN, Koufakis T, Zebekakis P, Kotsa K. Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun. World J Diabetes 2019; 10(4): 234-240
URL	https://www.wjgnet.com/1948-9358/full/v10/i4/234.htm
DOI	https://dx.doi.org/10.4239/wjd.v10.i4.234

Full Article (PDF)	WJD-10-234.pdf
Full Article (Word)	WJD-10-234.docx
Manuscript File	46796-Review.docx
Answering Reviewers	46796-Answering reviewers.pdf
Audio Core Tip	46796-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	46796-Conflict-of-interest statement.pdf
Copyright License Agreement	46796-Copyright license agreement.pdf
Peer-review Report	46796-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	46796-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	46796-Scientific misconduct check.pdf
Scientific Editor Work List	46796-Scientific editor work list.pdf
CrossCheck Report	46796-CrossCheck Report.pdf